OBA-PHARMA ApS: Financial statements 2022
CVR: 19995607
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
OBA-PHARMA ApS (CVR 19995607) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,041,316 and a net result of DKK 752,443 compared with DKK 1,001,773 the year before. That is a decrease of 21.9% compared with the year before. Equity in the 2022 report amounted to DKK 1,921,328. The solvency ratio was 29.1%.
- Gross Profit
- DKK 1,041,316
- Profit/Loss
- DKK 752,443
- Equity
- DKK 1,921,328
- Total Assets
- DKK 6,613,443
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1 mio. | 752 t. | 1.9 mio. | 0 |
| 2021 | - | 1.3 mio. | 1 mio. | 2.2 mio. | 0 |
| 2020 | - | 1.1 mio. | 865 t. | 1.2 mio. | 0 |
| 2019 | - | 2.3 mio. | 1.8 mio. | 2.3 mio. | - |
| 2018 | - | 2.5 mio. | 2.1 mio. | 6.5 mio. | - |
Official annual report
Keep an eye on OBA-PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
OBA-PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 1,333,640, and the net result was DKK 1,001,773.
About OBA-PHARMA ApS
OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees (2000). In 2024, the company reported a gross profit of DKK 3,402,201 and a net result of DKK 2,670,973 compared with DKK 2,073,440 the year before. Equity in the 2024 report amounted to DKK 674,251.